Confused between eczema and psoriasis? Experts explain how these skin conditions differ in symptoms, causes, and treatment.

Psoriasis is a long-term skin condition that affects millions of people around the world. It causes red, dry, and scaly ...

Organon recently presented post-hoc pooled Phase 3 ADORING 1 and 2 data showing VTAMA cream achieved early, statistically significant improvements in atopic dermatitis severity and itch versus vehicle ...

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...

Doctors say persistent nipple changes can sometimes signal Paget’s disease, a rare condition linked to breast cancer.

Presentations at the 2026 meeting of the American Academy of Dermatology not only demonstrate the therapeutic potential of ...

71.4% and 69.2% of patients treated with zasocitinib achieved a static Physician Global Assessment (sPGA) score of 0/1 versus placebo (10.7% and 12.6%) and apremilast (32.1% and 29.7%) at week 16 (p<0 ...

If you’re in need of a little boost to help get your day started, Irish brand Revive Active’s nutritional supplements are ...

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

Alumis Inc. ALMS shares tumbled Monday despite strong clinical trial outcomes, as investors locked in gains following a 239% ...

Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI 100 (41.0%, 39.5%)Quality-of-life improvements and itch ...

Jack Gevertz from Whitefield is using his experience with plaque psoriasis to support others facing the condition ...